P. Victória C. Ghignatti

Dr. P. Victória C. Ghignatti

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Brazilian Journal of Development
Verified
Journal Article
Open access
PDF file
PJPedro Henrique Mirapalheta Jacques
Pedro Henrique Mirapalheta Jacques
RSRita de Cássia dos Reis Schmidt
Rita de Cássia dos Reis Schmidt
HAHenrique Carvalho Andrade
Henrique Carvalho Andrade
PGP. Victória C. Ghignatti
P. Victória C. Ghignatti
JPJoão Marcelo Astolfi Picanço
João Marcelo Astolfi Picanço
ACAna Cristina Borba Cunha
Ana Cristina Borba Cunha
Metodologias ativas inovadoras no desenvolvimento de material pedagógico para o ensino de química / Innovative active methodologies in the development of pedagogical material for the teaching of chemistry

26 February 2026 in Cells
Verified
Journal Article
Open access
PDF file
PGP. Victória C. Ghignatti
P. Victória C. Ghignatti
RMRafael Aguiar Marschner
Rafael Aguiar Marschner
Rafael Teixeira RibeiroRafael Teixeira Ribeiro
Rafael Teixeira Ribeiro
VGVitor Gayger Gayger-Dias
Vitor Gayger Gayger-Dias
VSVanessa-Fernanda Da Silva
Vanessa-Fernanda Da Silva
PSPATRICIA SESTERHEIM
PATRICIA SESTERHEIM
Doxorubicin (DOX) is a highly effective chemotherapeutic agent whose clinical use is limited by dose-dependent cardiotoxicity associated with oxidative stress, inflammation, and cellular stress responses. Here, we investigated whether preventive aerobic training could protect against DOX-induced cardiac injury in Wistar rats. Animals were assigned to sedentary control (C), sedentary DOX (D), trained control (CT), and trained DOX (DT) groups. The moderate-intensity (~50–80% maximal exercise test) treadmill protocol (40 min/day, 4 days/week for 4 weeks) was performed before intraperitoneal administration of DOX (4 mg/kg, weekly for 4 weeks) or saline. Preventive training markedly improved exercise capacity (p < 0.001) and attenuated oxidative damage, maintaining antioxidant enzyme activity (GR, SOD) at control levels (p > 0.05). DOX significantly upregulated cardiac IL-6 and IL-1β expression (p < 0.01), while trained animals preserved IL-1β expression similar to controls (p > 0.99). In parallel, DOX increased cardiac HIF-1 expression (p < 0.05), indicating activation of hypoxia- and stress-related signaling pathways, an effect that was attenuated by preventive training (p > 0.99). DOX-induced cardiac atrophy was evidenced by reduced left ventricular mass (p < 0.001), which was partially prevented by training (p < 0.05). Although hematological toxicity persisted, preventive aerobic exercise effectively counteracted DOX cardiotoxicity by restoring redox homeostasis, dampening inflammation, and limiting apoptotic signaling. Collectively, these findings highlight exercise preconditioning as a promising non-pharmacological strategy in cardio-oncology to mitigate chemotherapy-associated cardiac injury.